New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

Drug Metabolism and Disposition Volume 33 Issue 4

2013
- Volume 41
  - Issue 2 (Feb)
  - Issue 1 (Jan)
2012
- Volume 40
2011
- Volume 39
2010
- Volume 38
2009
- Volume 37
2008
- Volume 36
2007
- Volume 35
2006
- Volume 34
2005
- Volume 33
2004
- Volume 32
2003
- Volume 31
2002
- Volume 30
2001
- Volume 29
2000
- Volume 28
1999
- Volume 27
1998
- Volume 26
1997
- Volume 25

Bookmark
More Like This gujEcwCLmq Preview Only

BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME

Takamura, Norito; Maruyama, Toru; Chosa, Etsuo; Kawai, Keiichi; Tsutsumi, Yasuhiro; Uryu, Yukie; Yamasaki, Keishi; Deguchi, Tsuneo; Otagiri, Masaki

Follow Drug Metabolism and Disposition , Volume 33 (4): 596 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This emjIdd6p01 Preview Only

CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OF N-HYDROXYMELAGATRAN AND BENZAMIDOXIME

Andersson, Susanne; Hofmann, Yvonne; Nordling, Åsa; Li, Xue-qing; Nivelius, Sabina; Andersson, Tommy B.; Ingelman-Sundberg, Magnus; Johansson, Inger

Follow Drug Metabolism and Disposition , Volume 33 (4): 570 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This B3r9BaxBZ9 Preview Only

Commentary: David Kupfer, Ph.D., 1925–2004

Schenkman, John

Follow Drug Metabolism and Disposition , Volume 33 (4): 483 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This 99vdZSmwV4 Preview Only

EFFECT OF EARLY PHASE ADJUVANT ARTHRITIS ON HEPATIC P450 ENZYMES AND PHARMACOKINETICS OF VERAPAMIL: AN ALTERNATIVE APPROACH TO THE USE OF AN ANIMAL MODEL OF INFLAMMATION FOR PHARMACOKINETIC STUDIES

Ling, Spencer; Jamali, Fakhreddin

Follow Drug Metabolism and Disposition , Volume 33 (4): 579 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This 63bemEOvDF Preview Only

IN VITRO METABOLISM OF DIARYLPYRAZOLES, A NOVEL GROUP OF CANNABINOID RECEPTOR LIGANDS

Zhang, Qiang; Ma, Peng; Wang, Weiqun; Cole, Richard B.; Wang, Guangdi

Follow Drug Metabolism and Disposition , Volume 33 (4): 508 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This R74cIh8VYr Preview Only

IDENTIFICATION OF A NOVEL GLUTATHIONE ADDUCT OF DICLOFENAC, 4′-HYDROXY-2′-GLUTATHION-DESCHLORO-DICLOFENAC, UPON INCUBATION WITH HUMAN LIVER MICROSOMES

Yu, Li J.; Chen, Yue; Deninno, Michael P.; O'Connell, Thomas N.; Hop, Cornelis E. C. A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 484 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This RORGmjIvqA Preview Only

DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1

Chen, Cuiping; Mireles, Rouchelle J.; Campbell, Scott D.; Lin, Jian; Mills, Jessica B.; Xu, Jinghai J.; Smolarek, Teresa A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 537 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This p0gjUEnC9Y Preview Only

CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B

Satoh, Hiroki; Yamashita, Fumiaki; Tsujimoto, Masayuki; Murakami, Hideyasu; Koyabu, Noriko; Ohtani, Hisakazu; Sawada, Yasufumi

Follow Drug Metabolism and Disposition , Volume 33 (4): 518 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This ayyslUuYSs Preview Only

SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV

Walker, Don K.; Abel, Samantha; Comby, Pierre; Muirhead, Gary J.; Nedderman, Angus N. R.; Smith, Dennis A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 587 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005
Bookmark
More Like This lPBCdUCbTb Preview Only

FUNCTIONAL INDUCTION AND DE-INDUCTION OF P-GLYCOPROTEIN BY ST. JOHN'S WORT AND ITS INGREDIENTS IN A HUMAN COLON ADENOCARCINOMA CELL LINE

Tian, Run; Koyabu, Noriko; Morimoto, Satoshi; Shoyama, Yukihiro; Ohtani, Hisakazu; Sawada, Yasufumi

Follow Drug Metabolism and Disposition , Volume 33 (4): 547 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Drug Metabolism and Disposition Volume 33 Issue 4

BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME

Takamura, Norito; Maruyama, Toru; Chosa, Etsuo; Kawai, Keiichi; Tsutsumi, Yasuhiro; Uryu, Yukie; Yamasaki, Keishi; Deguchi, Tsuneo; Otagiri, Masaki

Follow Drug Metabolism and Disposition , Volume 33 (4): 596 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OF N-HYDROXYMELAGATRAN AND BENZAMIDOXIME

Andersson, Susanne; Hofmann, Yvonne; Nordling, Åsa; Li, Xue-qing; Nivelius, Sabina; Andersson, Tommy B.; Ingelman-Sundberg, Magnus; Johansson, Inger

Follow Drug Metabolism and Disposition , Volume 33 (4): 570 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Commentary: David Kupfer, Ph.D., 1925–2004

Schenkman, John

Follow Drug Metabolism and Disposition , Volume 33 (4): 483 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

EFFECT OF EARLY PHASE ADJUVANT ARTHRITIS ON HEPATIC P450 ENZYMES AND PHARMACOKINETICS OF VERAPAMIL: AN ALTERNATIVE APPROACH TO THE USE OF AN ANIMAL MODEL OF INFLAMMATION FOR PHARMACOKINETIC STUDIES

Ling, Spencer; Jamali, Fakhreddin

Follow Drug Metabolism and Disposition , Volume 33 (4): 579 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

IN VITRO METABOLISM OF DIARYLPYRAZOLES, A NOVEL GROUP OF CANNABINOID RECEPTOR LIGANDS

Zhang, Qiang; Ma, Peng; Wang, Weiqun; Cole, Richard B.; Wang, Guangdi

Follow Drug Metabolism and Disposition , Volume 33 (4): 508 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

IDENTIFICATION OF A NOVEL GLUTATHIONE ADDUCT OF DICLOFENAC, 4′-HYDROXY-2′-GLUTATHION-DESCHLORO-DICLOFENAC, UPON INCUBATION WITH HUMAN LIVER MICROSOMES

Yu, Li J.; Chen, Yue; Deninno, Michael P.; O'Connell, Thomas N.; Hop, Cornelis E. C. A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 484 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1

Chen, Cuiping; Mireles, Rouchelle J.; Campbell, Scott D.; Lin, Jian; Mills, Jessica B.; Xu, Jinghai J.; Smolarek, Teresa A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 537 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B

Satoh, Hiroki; Yamashita, Fumiaki; Tsujimoto, Masayuki; Murakami, Hideyasu; Koyabu, Noriko; Ohtani, Hisakazu; Sawada, Yasufumi

Follow Drug Metabolism and Disposition , Volume 33 (4): 518 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV

Walker, Don K.; Abel, Samantha; Comby, Pierre; Muirhead, Gary J.; Nedderman, Angus N. R.; Smith, Dennis A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 587 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

FUNCTIONAL INDUCTION AND DE-INDUCTION OF P-GLYCOPROTEIN BY ST. JOHN'S WORT AND ITS INGREDIENTS IN A HUMAN COLON ADENOCARCINOMA CELL LINE

Tian, Run; Koyabu, Noriko; Morimoto, Satoshi; Shoyama, Yukihiro; Ohtani, Hisakazu; Sawada, Yasufumi

Follow Drug Metabolism and Disposition , Volume 33 (4): 547 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Advanced Filters:

Specific Data Sources:

Drug Metabolism and Disposition Volume 33 Issue 4

1 - 10 of 17 articles

Takamura, Norito; Maruyama, Toru; Chosa, Etsuo; Kawai, Keiichi; Tsutsumi, Yasuhiro; Uryu, Yukie; Yamasaki, Keishi; Deguchi, Tsuneo; Otagiri, Masaki

Follow Drug Metabolism and Disposition , Volume 33 (4): 596 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Andersson, Susanne; Hofmann, Yvonne; Nordling, Åsa; Li, Xue-qing; Nivelius, Sabina; Andersson, Tommy B.; Ingelman-Sundberg, Magnus; Johansson, Inger

Follow Drug Metabolism and Disposition , Volume 33 (4): 570 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Follow Drug Metabolism and Disposition , Volume 33 (4): 483 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Ling, Spencer; Jamali, Fakhreddin

Follow Drug Metabolism and Disposition , Volume 33 (4): 579 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Zhang, Qiang; Ma, Peng; Wang, Weiqun; Cole, Richard B.; Wang, Guangdi

Follow Drug Metabolism and Disposition , Volume 33 (4): 508 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Yu, Li J.; Chen, Yue; Deninno, Michael P.; O'Connell, Thomas N.; Hop, Cornelis E. C. A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 484 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Chen, Cuiping; Mireles, Rouchelle J.; Campbell, Scott D.; Lin, Jian; Mills, Jessica B.; Xu, Jinghai J.; Smolarek, Teresa A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 537 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Satoh, Hiroki; Yamashita, Fumiaki; Tsujimoto, Masayuki; Murakami, Hideyasu; Koyabu, Noriko; Ohtani, Hisakazu; Sawada, Yasufumi

Follow Drug Metabolism and Disposition , Volume 33 (4): 518 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Walker, Don K.; Abel, Samantha; Comby, Pierre; Muirhead, Gary J.; Nedderman, Angus N. R.; Smith, Dennis A.

Follow Drug Metabolism and Disposition , Volume 33 (4): 587 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005

Tian, Run; Koyabu, Noriko; Morimoto, Satoshi; Shoyama, Yukihiro; Ohtani, Hisakazu; Sawada, Yasufumi

Follow Drug Metabolism and Disposition , Volume 33 (4): 547 Am. Soc for Pharma & Experimental Therapeutics – Apr 1, 2005